In 2025, CytomX remained focused on controlling costs and efficiently progressing its pipeline programs. Total operating expense for 2025 was $98.6 million compared to $113.1 million for 2024, a ...
The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...
Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...
CRANFORD, N.J., March 10, 2026 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology?focused biopharmaceutical company and majority ...
Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...
Please provide your email address to receive an email when new articles are posted on . Infusion-related reactions occurred at similar rates for 30-minute and 10-minute pembrolizumab infusions.
Panelists discuss how the muscarinic pathway of xanomeline/trospium offers a safer, nondopaminergic approach to schizophrenia care. Panelists discuss how xanomeline/trospium chloride introduces a ...
Following on from the wonderful It Takes Two, developer Hazelight took things to the next level when it comes to scale in Split Fiction and continued to hone its craft as the modern-day masters of the ...
Disney’s live-action remake of ‘Moana’ released a first-look trailer, and fans were confused about why the film is being released in the first place. The first trailer for Disney’s latest live-action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results